Clinical Trial Update: PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB [NA]

View source ↗

Summary

This is a PMCF (post-market clinical follow-up) study update for the Axonics sacral neuromodulation system Model 5101 (R20) evaluating its indication in overact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Frequency
• Urinary Urge Incontinence

Drugs mentioned

• Axonics SNM System Model 5101 (R20)

Snippet

Sponsor: Axonics, Inc. | Conditions: Urinary Urge Incontinence (UUI), Urinary Frequency (UF) | NA | Status: RECRUITING